External seminar – Dr Fabien ALPY le 16 décembre à 10h30
Fabien Alpy from IGBMC (Strasbourg) will present is seminar on december the 16th et10h30 salle Hervé Paris : “MOSPD2 is an Endoplasmic Reticulum–Lipid Droplet Tether Functioning in LD Homeostasis”. Teams link :...
The I2MC is looking for a new group leader
Group Leader Position at the Institute of Metabolic & Cardiovascular Disease Job description The Institute of Metabolic and Cardiovascular Diseases (I2MC, Inserm, University of Toulouse, www.i2mc.inserm.fr/en) is looking for a young scientist or an established...
EndoTreat: research project conducted in partnership with the Toulouse University Hospital (E. Chantalat), INSERM-I2MC (F. Lenfant) and the start-up company Urosphère
Endometriosis: researchers in Toulouse study the disease by creating organoids (Equipe de Françoise LENFANT) Click here to read article in the Dépêche. To better understand the mechanisms of endometriosis, an oestrogen-dependent disease that affects 10% of women in...
We-Met involved in Europen project HERVCOV
The protein that opens doors to the medicine of the future and treatment of COVID-19 “Understand the pathogenic role of HERV-W envelope protein and develop novel prognostic markers and therapeutic targets for personalized treatment of COVID-19-associated...
Recent Comments